Detection of cancer DNA in early stage and metastatic breast cancer patients

Arielle J. Medford, Riaz N. Gillani, Ben Ho Park

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Breast cancer is the leading cause of cancer in women and the second leading cause of cancer-related death. There are many subtypes of breast cancer, which can be identified through the process of molecular and genetic profiling. While the current standard of care utilizes tumor tissue biopsy to subclassify breast cancer, plasma tumor DNA (ptDNA) can be detected through droplet digital PCR (ddPCR) of plasma obtained from a simple blood draw. Tissue biopsy is not only more invasive but because tumors exhibit heterogeneity it can be less accurate. Blood collects DNA shed from normal and cancerous cells alike, thus ddPCR of plasma offers a broader picture of a cancer’s genetic makeup. This chapter summarizes how patients with breast cancer can be screened for specific cancerous mutations in both tissue and plasma through the use of ddPCR.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages209-227
Number of pages19
DOIs
StatePublished - Jan 1 2018

Publication series

NameMethods in Molecular Biology
Volume1768
ISSN (Print)1064-3745

Fingerprint

Breast Neoplasms
DNA
Neoplasms
Polymerase Chain Reaction
Biopsy
Standard of Care
Molecular Biology
Mutation

Keywords

  • Biopsy
  • Blood
  • Breast cancer
  • Droplet digital
  • Liquid biopsy
  • PCR
  • PIK3CA
  • Plasma

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Medford, A. J., Gillani, R. N., & Park, B. H. (2018). Detection of cancer DNA in early stage and metastatic breast cancer patients. In Methods in Molecular Biology (pp. 209-227). (Methods in Molecular Biology; Vol. 1768). Humana Press Inc.. https://doi.org/10.1007/978-1-4939-7778-9_13

Detection of cancer DNA in early stage and metastatic breast cancer patients. / Medford, Arielle J.; Gillani, Riaz N.; Park, Ben Ho.

Methods in Molecular Biology. Humana Press Inc., 2018. p. 209-227 (Methods in Molecular Biology; Vol. 1768).

Research output: Chapter in Book/Report/Conference proceedingChapter

Medford, AJ, Gillani, RN & Park, BH 2018, Detection of cancer DNA in early stage and metastatic breast cancer patients. in Methods in Molecular Biology. Methods in Molecular Biology, vol. 1768, Humana Press Inc., pp. 209-227. https://doi.org/10.1007/978-1-4939-7778-9_13
Medford AJ, Gillani RN, Park BH. Detection of cancer DNA in early stage and metastatic breast cancer patients. In Methods in Molecular Biology. Humana Press Inc. 2018. p. 209-227. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-4939-7778-9_13
Medford, Arielle J. ; Gillani, Riaz N. ; Park, Ben Ho. / Detection of cancer DNA in early stage and metastatic breast cancer patients. Methods in Molecular Biology. Humana Press Inc., 2018. pp. 209-227 (Methods in Molecular Biology).
@inbook{00fe7b4d8e534739b7a1fee6920044de,
title = "Detection of cancer DNA in early stage and metastatic breast cancer patients",
abstract = "Breast cancer is the leading cause of cancer in women and the second leading cause of cancer-related death. There are many subtypes of breast cancer, which can be identified through the process of molecular and genetic profiling. While the current standard of care utilizes tumor tissue biopsy to subclassify breast cancer, plasma tumor DNA (ptDNA) can be detected through droplet digital PCR (ddPCR) of plasma obtained from a simple blood draw. Tissue biopsy is not only more invasive but because tumors exhibit heterogeneity it can be less accurate. Blood collects DNA shed from normal and cancerous cells alike, thus ddPCR of plasma offers a broader picture of a cancer’s genetic makeup. This chapter summarizes how patients with breast cancer can be screened for specific cancerous mutations in both tissue and plasma through the use of ddPCR.",
keywords = "Biopsy, Blood, Breast cancer, Droplet digital, Liquid biopsy, PCR, PIK3CA, Plasma",
author = "Medford, {Arielle J.} and Gillani, {Riaz N.} and Park, {Ben Ho}",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-7778-9_13",
language = "English (US)",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "209--227",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Detection of cancer DNA in early stage and metastatic breast cancer patients

AU - Medford, Arielle J.

AU - Gillani, Riaz N.

AU - Park, Ben Ho

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Breast cancer is the leading cause of cancer in women and the second leading cause of cancer-related death. There are many subtypes of breast cancer, which can be identified through the process of molecular and genetic profiling. While the current standard of care utilizes tumor tissue biopsy to subclassify breast cancer, plasma tumor DNA (ptDNA) can be detected through droplet digital PCR (ddPCR) of plasma obtained from a simple blood draw. Tissue biopsy is not only more invasive but because tumors exhibit heterogeneity it can be less accurate. Blood collects DNA shed from normal and cancerous cells alike, thus ddPCR of plasma offers a broader picture of a cancer’s genetic makeup. This chapter summarizes how patients with breast cancer can be screened for specific cancerous mutations in both tissue and plasma through the use of ddPCR.

AB - Breast cancer is the leading cause of cancer in women and the second leading cause of cancer-related death. There are many subtypes of breast cancer, which can be identified through the process of molecular and genetic profiling. While the current standard of care utilizes tumor tissue biopsy to subclassify breast cancer, plasma tumor DNA (ptDNA) can be detected through droplet digital PCR (ddPCR) of plasma obtained from a simple blood draw. Tissue biopsy is not only more invasive but because tumors exhibit heterogeneity it can be less accurate. Blood collects DNA shed from normal and cancerous cells alike, thus ddPCR of plasma offers a broader picture of a cancer’s genetic makeup. This chapter summarizes how patients with breast cancer can be screened for specific cancerous mutations in both tissue and plasma through the use of ddPCR.

KW - Biopsy

KW - Blood

KW - Breast cancer

KW - Droplet digital

KW - Liquid biopsy

KW - PCR

KW - PIK3CA

KW - Plasma

UR - http://www.scopus.com/inward/record.url?scp=85046378355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046378355&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-7778-9_13

DO - 10.1007/978-1-4939-7778-9_13

M3 - Chapter

C2 - 29717446

AN - SCOPUS:85046378355

T3 - Methods in Molecular Biology

SP - 209

EP - 227

BT - Methods in Molecular Biology

PB - Humana Press Inc.

ER -